NCT02022384View on ClinicalTrials.gov

Immunophenotyping From Blood of Patients With Malignant Gliomas

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Anaplastic AstrocytomaGlioblastoma Multiforme
Interventions
OTHER

Blood sample and life quality questionnaires

Blood will be drawn at distinct time points during and after radio(chemo)therapy

Trial Locations (1)

91054

Departement of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität erlangen-Nürnberg, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT02022384 - Immunophenotyping From Blood of Patients With Malignant Gliomas | Biotech Hunter | Biotech Hunter